PWM
MIRA icon

Praetorian Wealth Management’s MIRA Pharmaceuticals MIRA Stock Holding History

Praetorian Wealth Management’s Portfolio MIRA Stock Details MIRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-17,500
Closed -$17.1K – 49
2025
Q1 		$17.1K Hold
17,500
– – ﹤0.01% 58
2024
Q4 		$19.9K Hold
17,500
– – ﹤0.01% 61
2024
Q3 		$22.8K Sell
17,500
-10,000
-36% -$15.9K 0.01% 36
2024
Q2 		$17.5K Hold
27,500
– – ﹤0.01% 57
2024
Q1 		$30.3K Buy
+27,500
New +$29.9K 0.01% 35

Other funds holding MIRA

CSI
Cross Staff Investments Pittsford, New York $197M AUM 14.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SEM
Suncoast Equity Management Tampa, Florida $833M AUM 11.9% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JWCA
J.W. Cole Advisors Tampa, Florida $5.83B AUM 32.38% 1-Year Est. Return
IAIM
International Assets Investment Management Orlando, Florida $1.44B AUM 21.92% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return

Praetorian Wealth Management's MIRA Position: Q2 2025 in Review

Praetorian Wealth Management sold out of MIRA Pharmaceuticals (MIRA) in Q2 2025, closing a stake of 17,500 shares — an estimated $17.1K sold.

Praetorian Wealth Management first reported a position in MIRA in Q1 2024 and held it in 5 quarters. The position peaked at $30.3K in Q1 2024. 20 funds tracked by Wall St. Rank hold MIRA as of Q2 2025.

  • Praetorian Wealth Management reported no remaining MIRA Pharmaceuticals position as of Q2 2025 after selling out during the quarter.
  • Praetorian Wealth Management sold 17,500 MIRA Pharmaceuticals shares in Q2 2025, an estimated $17.1K.
  • Praetorian Wealth Management first reported a position in MIRA Pharmaceuticals in Q1 2024 and held it in 5 quarters.
  • Praetorian Wealth Management's MIRA Pharmaceuticals position peaked at $30.3K in Q1 2024.
  • 20 funds tracked by Wall St. Rank held MIRA Pharmaceuticals as of Q2 2025.

Based on Praetorian Wealth Management's 13F filing for Q2 2025, filed 9 Jul 2025.